IN Brief:
- Everything Sprouts recalled specified alfalfa products on 22 August after federal traceback linked the sprouts to a multistate outbreak.
- Authorities reported 55 illnesses across 15 states, including four hospitalisations and infections involving several STEC strains and Salmonella.
- FDA inspection and sampling at the Minneapolis operation are continuing, with the contamination source not yet established.
Everything Sprouts has recalled specified lots of alfalfa sprouts after federal investigators linked its products to a multistate outbreak involving several Shiga toxin-producing E. coli strains and Salmonella.
The Minneapolis manufacturer announced the recall on 22 August, following an FDA and CDC investigation that had identified 55 illnesses across 15 states. Four people had been hospitalised and no deaths had been reported at the time of the latest federal case update.
The recall covers alfalfa sprouts sold under the Everything Sprouts and Calco brands in specified five-ounce packs and tray configurations. The same alfalfa sprouts were also used in Everything Sprouts Crunchy Protein Sprout Mix and Zesty Garlic Mix products, meaning the recall extends beyond packs containing only the single sprout variety.
Affected alfalfa products include lots 222, 223, 225, 226, and 230, although the lot coverage varies between the mixed-sprout products. Everything Sprouts says the recalled items were distributed between 27 May and 21 August to wholesale distributors and grocery stores in Minnesota and Wisconsin.
The public-health investigation covers a wider geography. FDA says cases have been reported across 15 states and that additional distribution information is still being investigated, so the known retail distribution area should not be treated as the final boundary of the outbreak.
Sprouting creates unusual microbiological conditions
Alfalfa sprouts are a difficult product to control because germination requires warm and humid conditions that can also support bacterial growth. If pathogenic organisms are already present at low levels on seed or enter the process during production, the sprouting environment can allow them to multiply before the finished product reaches consumers.
That places greater emphasis on prevention upstream. Seed sourcing, sanitation, irrigation-water management, equipment hygiene, environmental controls, and verification testing all become part of the production system, while there is no routine final cooking stage on raw sprouts that can be relied upon to eliminate contamination before consumption.
The current outbreak involves more than one pathogen. FDA says illnesses include STEC O26:H11, O103:H25 and O168:H8, alongside Salmonella Agona. Of the 55 reported cases, 46 involved E. coli, seven involved Salmonella, and two people were infected with both.
That combination makes the plant investigation particularly important. FDA began an inspection and sample collection at Everything Sprouts on 19 August and says work is continuing to determine the source of contamination and whether additional products or businesses are linked to the outbreak.
The published evidence does not yet establish whether the problem originated with seed, water, equipment, the production environment, or another route. Historical FDA work has identified contaminated seed as an important source in sprout-associated Salmonella outbreaks, but applying that general finding to the current incident before laboratory and traceback work is complete would be premature.
Lot genealogy now defines the recall
The industrial task is to establish how the implicated alfalfa moved through production. The fact that the same sprouts were incorporated into mixed products illustrates why food manufacturers need traceability below the finished-stock level: one ingredient or production lot can feed several retail products and therefore create several recall paths.
Accurate genealogy allows the manufacturer to connect incoming seed, individual growing or harvesting batches, packed alfalfa sprouts, mixed-product runs, and customer shipments. If those records remain precise, the company can keep the recall limited to demonstrably affected production. If they do not, the safest commercial response is usually to widen the boundary.
FDA traceback from restaurants and grocery stores identified alfalfa sprouts distributed by Everything Sprouts as a source of illness. Among 34 people interviewed about the foods they ate before becoming ill, 26 reported eating alfalfa sprouts, giving investigators a strong epidemiological signal alongside the supply-chain work.
Retailers and distributors holding affected lots have been told to stop selling or distributing them and dispose of the product according to local protocols. FDA and the company also advise cleaning and sanitising surfaces or containers that may have contacted the sprouts, reflecting the potential for contamination to move beyond the original package.
The timing of the illnesses demonstrates another difficulty in fresh-produce investigations. Reported onset dates range from 31 May to 8 August, while the company recall was issued on 22 August. By the time epidemiological links are strong enough to trigger broad action, much of a short-shelf-life product may have passed through the supply chain or been consumed.
Everything Sprouts says it is continuing to work with public-health officials while the source is investigated. FDA likewise describes the outbreak as ongoing and may update the advisory if further distribution, product, or laboratory information becomes available.
The recall therefore provides a defined set of lots and brands for removal, but it does not mark the end of the manufacturing investigation. The next meaningful finding will be whether inspectors and traceability records can establish where contamination entered the process and whether the existing recall boundary captures all production connected to it.
